These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9558424)

  • 1. Drug stability and pyridine generation in ceftazidime injection stored in an elastomeric infusion device.
    Stendal TL; Klem W; Tønnesen HH; Kjønniksen I
    Am J Health Syst Pharm; 1998 Apr; 55(7):683-5. PubMed ID: 9558424
    [No Abstract]   [Full Text] [Related]  

  • 2. Fortum stability in different disposable infusion devices by pyridine assay.
    Favetta P; Allombert C; Breysse C; Dufresne C; Guitton J; Bureau J
    J Pharm Biomed Anal; 2002 Mar; 27(6):873-9. PubMed ID: 11836051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftazidime degradation rates for predicting stability in a portable infusion-pump reservoir.
    van Doorne H; Bernaards J; de Jonge P
    Am J Health Syst Pharm; 1996 Jun; 53(11):1302-5. PubMed ID: 8725207
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative stability studies of antipseudomonal beta-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units).
    Viaene E; Chanteux H; Servais H; Mingeot-Leclercq MP; Tulkens PM
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2327-32. PubMed ID: 12121900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of reconstituted solutions of ceftazidime for injections: an HPLC and CE approach.
    Farina A; Porrà R; Cotichini V; Doldo A
    J Pharm Biomed Anal; 1999 Jul; 20(3):521-30. PubMed ID: 10701968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of ceftazidime (with arginine) in an elastomeric infusion device.
    Bednar DA; Klutman NE; Henry DW; Fox JL; Strayer AH
    Am J Health Syst Pharm; 1995 Sep; 52(17):1912-4. PubMed ID: 8528856
    [No Abstract]   [Full Text] [Related]  

  • 7. Liquid chromatographic method to follow-up ceftazidime and pyridine in portable elastomeric infusion pumps over 24 h.
    Nguyen T; Menten L; Spriet I; Quintens C; Van Schepdael A; Adams E
    Electrophoresis; 2022 May; 43(9-10):970-977. PubMed ID: 34780670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of ceftazidime in a viscous eye drop formulation.
    Barnes AR; Nash S
    J Clin Pharm Ther; 1999 Aug; 24(4):299-302. PubMed ID: 10475988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of ceftazidime in normal saline solution after exposure to light.
    Jaruratanasirikul S; Sriwiriyajan S
    Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):216-8. PubMed ID: 11485088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of high-dose vancomycin and ceftazidime in peritoneal dialysis solutions.
    Stamatakis MK; Leader WG; Tracy TS
    Am J Health Syst Pharm; 1999 Feb; 56(3):246-8. PubMed ID: 10030511
    [No Abstract]   [Full Text] [Related]  

  • 11. Stability of ceftazidime in 1% and 5% buffered eye drops determined with HPLC method.
    Kodym A; Hapka-Zmich D; Gołab M; Gwizdala M
    Acta Pol Pharm; 2011; 68(1):99-107. PubMed ID: 21485707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of ceftizoxime sodium, ceftriaxone sodium, and ceftazidime with metronidazole in ready-to-use metronidazole bags.
    Rivers TE; Webster AA
    Am J Health Syst Pharm; 1995 Nov; 52(22):2568-70. PubMed ID: 8590243
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of carbohydrates and polyhydric alcohols on the stability of ceftazidime in aqueous solution.
    Zajac M; Siwek J
    Acta Pol Pharm; 1995; 52(2):87-90. PubMed ID: 8984848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of ceftazidime (with arginine) and of cefuroxime sodium in infusion-pump reservoirs.
    Stiles ML; Allen LV; Fox JL
    Am J Hosp Pharm; 1992 Nov; 49(11):2761-4. PubMed ID: 1471642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of ceftazidime sodium and teicoplanin sodium in a peritoneal dialysis solution.
    Manduru M; Fariello A; White RL; Fox JL; Bosso JA
    Am J Health Syst Pharm; 1996 Nov; 53(22):2731-4. PubMed ID: 8931816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compatibility and stability of linezolid injection admixed with three cephalosporin antibiotics.
    Xu QA; Trissel LA; Williams KY
    J Am Pharm Assoc (Wash); 2000; 40(4):509-14. PubMed ID: 10932460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of tacrolimus with morphine sulfate, hydromorphone hydrochloride, and ceftazidime during simulated intravenous coadministration.
    Johnson CE; VandenBussche HL; Chio CC; Jacobson PA
    Am J Health Syst Pharm; 1999 Jan; 56(2):164-9. PubMed ID: 10030533
    [No Abstract]   [Full Text] [Related]  

  • 18. Continuous infusion of ceftazidime with an elastomeric infusion device.
    Couldry R; Sanborn M; Klutman NE; Strayer AH
    Am J Health Syst Pharm; 1998 Jan; 55(2):145-9. PubMed ID: 9465978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of hydrolysis of ceftazidime in aqueous solutions.
    Siwek J; Zajac M
    Acta Pol Pharm; 1995; 52(1):21-30. PubMed ID: 8984847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of ceftazidime degradation in aqueous solutions.
    Zajac M; Siwek J; Muszalska I
    Acta Pol Pharm; 1998; 55(4):275-8. PubMed ID: 9821392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.